Malignant A-to-I RNA editing by ADAR1 drives T cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing is a research paper published in Cell Reports (2024). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: K22 CA229606
NCI NIH HHS
Grant: R01 CA282792
NCATS NIH HHS
Grant: UL1 TR001442
NCI NIH HHS
Grant: R01 CA205944
NCI NIH HHS
Grant: R03 CA287274
National Institutes of Health
Grant: 5R01CA205944-04
Characterization of the Role of ADAR1 in Oncogenic Transformation of Progenitors
National Institutes of Health
Grant: 5K22CA229606-03
Investigating the role of epitranscriptomic A-to-I RNA editing in T-cell acute lymphoblastic leukemia
National Institutes of Health
Grant: 2UL1TR001442-06
UC San Diego Clinical and Translational Research Institute
FWCI
5.07
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals